The proposals will help MedTech developers access NHS funding to fast-track products
News
LifeArc and ALS TDI announce partnership to develop new clinical tools for ALS and MND
The project will validate two minimally invasive biomarkers for ALS: MMP-9 and TIMP-1
MRC awards two medical research units at University of Cambridge £30m in funding
The MRC BRC and the MDU will use the funding and cutting-edge research to improve public health until March 2029
King’s Doctoral Training Centre to investigate MS symptom management
Impacting more than 150,000 people in the UK, the lifelong autoimmune disease affects the brain and spinal cord
Agenda announced for FlyPharma Vienna 2024
The conference will take place on 23 to 24 October at Vienna AirportCity
Therapy reprogrammes immune cells to shrink prostate and bladder cancers
JHU083 reduced tumour growth and triggered tumour cell death in mice
Researchers combine herpes virus with cancer vaccine to treat brain cancer in children
High-grade gliomas are rare, malignant tumours which account for up to 12% of all childhood brain tumours
UK MRC and AstraZeneca partner for translational clinical research
The partnership will provide six MRC clinical fellows with industry placement opportunities
UK lung cancer study demonstrates further evidence on importance of CT screening
Currently the third most common cancer in the UK, lung cancer affects 40,000 people annually
New ‘plug and play’ system to offer novel way of delivering vaccines and treatments
The nanocage technology combines both mRNA and traditional virus-based vaccines to create virus-like efficacious vaccines
NHS addresses shortage of ethnic organ and blood donors with £600,000 funding
The funding aims to reduce health inequalities in these groups and save more lives
NIHR awards HealthTech Research Centre Network £5m to advance health innovations
The network will support the development, evaluation and adoption of innovative health and care technology
KCL researchers identify key features of autoimmune diseases present in the gut
Globally affecting 4% of the population, autoimmune diseases mistakenly attack healthy cells, tissues and organs in the body
Vicore and Endeavor’s therapies show promise in treating IPF
Both drugs have the potential to offer a disease-modifying approach to the lung disease
Liverpool and McMaster University announce £300,000 strategic research partnership
Areas include health research across life stages, from paediatrics to health ageing and resilience
